Business
Edison issues research update on Angle
Edison issues research update on Angle.
About this update from Cellbxhealth Plc
[{"type":"text","content":"\n \nRNS Number : 5816Z Angle PLC 27 May 2016 \n\n \nLondon, UK, 27 May 2016\nEdison issues research update on Angle\nAngle has raised £9.6m (net) via a private placing. This supports Angle's focus on commercialising Parsortix, with the funds being applied to a range of clinical studies to demonstrate utility of the Parsortix system. Additionally, Angle announced that Cancer Research UK Manchester Institute is adopting Parsortix for routine research use, which will provide recurring sales. FY16 results in July will provide a trading update and more details on the R&D expansion strategy, likely to be scaled up with the benefit of the fund raising.\n \nWe will review our forecasts and valuation after the FY16 results in July. We see the private placement as a first step towards initiating clinical trials with new indications, giving scope for future valuation uplift (albeit diluted by the new shares for now).\n \nClick here to view the full report \n \nAll reports published by Edison are available to download free of charge from its website: www.edisoninvestmentresearch.com\n \nAbout Edison: Edison is an international equity research firm with a team of over 110 analysts, investment and roadshow professionals and works with both large and smaller capitalised companies, blue chip institutional investors, wealth managers, private equity and corporate finance houses to support their capital markets activity. Edison provides services to more than 420 retained corporate and investor clients from offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority.\n \nEdison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.\nContact details: Learn more at www.edisongroup.com and connect with Edison on: \n\n\n\n\nLinkedIn\n\n\nwww.linkedin.com/company/edison-investment-research\n\n\n\n\nTwitter\n\n\nwww.twitter.com/Edison_Inv_Res \n\n\n\n\nYouTube\n\n\nwww.youtube.com/edisonitv\n\n\n\n\nGoogle+\n\n\nhttps://plus.google.com/105425025202328783163/posts\n\n\n\n\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange END NRAGMGZKDNRGVZM\n ","length":4597,"tagName":"di...